ArticleScience advances2026
Strain-specific epistasis shapes fitness landscapes of APOBEC3G antagonism by HIV-1 Vif proteins.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The structural mechanism of HIV-2 Vif antagonism of human APOBEC3H.Nature communications · 2026Article
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
Host immune factors shape viral evolution. The HIV-1 viral infectivity factor (Vif) protein counteracts host Apolipoprotein B Messenger RNA Editing Enzyme Catalytic Polypeptide-like 3 (A3G) to ensure productive infection. Using deep mutational scanning across two divergent HIV-1 Vif proteins, we systematically mapped and compared the mutational landscapes governing Vif antagonism of A3G. These high-resolution fitness maps reveal core principles of host-virus coevolution. Most missense mutations were strongly deleterious, reflecting pervasive purifying selection. However, several highly conserved Vif residues at binding interfaces with A3G, RNA, and core-binding factor β exhibited unexpected mutational tolerance, indicating structural flexibility at these sites. Comparative analysis revealed that strain-specific epistasis dictates Vif-A3G interactions, including adaptive changes at the Vif-A3G interface. Further analysis uncovered notable temporal epistasis, whereby initially adaptive Vif mutations critical for antagonizing hominoid A3G subsequently exhibited reduced fitness. Thus, structural robustness permits adaptation, while epistasis imposes constraints on Vif's ability to maintain A3G antagonism while remaining responsive to new evolutionary pressures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.